Essure hysteroscopic tubal occlusion device for the treatment of hydrosalpinx prior to in vitro fertilization-embryo transfer in patients with a contraindication for laparoscopy

Fertility and Sterility

Volumn 93, Issue 4, 2010, Pages 1338-1342

  Mijatovic, Velja ^a   Veersema, Sebastiaan ^b   Emanuel, Mark Hans ^c   Schats, Roel ^a   Hompes, Peter G A ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ST ANTONIUS HOSPITAL   (Netherlands)

^c Infection and Immunology   (Netherlands)

Author keywords

Essure hysteroscopic tubal occlusion; hydrosalpinges; IVF ET

Indexed keywords

ADULT; ARTICLE; BIRTH; CLINICAL ARTICLE; CLINICAL STUDY; DELIVERY; DEVICE; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; FOLLOW UP; HUMAN; HYDROSALPINX; HYSTEROSALPINGOGRAPHY; HYSTEROSCOPY; LAPAROSCOPY; PREGNANCY RATE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SALPINGECTOMY; SUBFERTILITY; TEACHING HOSPITAL; TREATMENT CONTRAINDICATION; UNIVERSITY HOSPITAL; UTERINE TUBE OCCLUSION;

ADULT; EMBRYO TRANSFER; FALLOPIAN TUBES; FEMALE; FERTILIZATION IN VITRO; HUMANS; HYSTEROSCOPY; INFANT, NEWBORN; INFERTILITY, FEMALE; LAPAROSCOPY; PREGNANCY; PROSPECTIVE STUDIES;

EID: 77049101955     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2008.11.022     Document Type: Article

References (19)

1. Andersen A.N., Lindhard A., Loft A., Ziebe S., and Andersen C.Y. The infertile patient with hydrosalpinges. IVF with or without salpingectomy?. Hum Reprod 11 (1996) 2081-2084
2. Zeyneloglu H.B., Arici A., and Olive D.L. Adverse effects of hydrosalpinx on pregnancy rates after in vitro fertilization-embryo transfer. Fertil Steril 70 (1998) 492-499
3. Camus E., Poncelet C., Goffinet F., et al. Pregnancy rates after IVF in cases of tubal infertility with and without hydrosalpinx: meta-analysis of published comparative studies. Hum Reprod 14 (1999) 1243-1249
4. De Wit W., Gowrising C.J., Kuik D.J., Lens J.W., and Schats R. Only hydrosalpinges visible on ultrasound are associated with reduced implantation and pregnancy rates after in vitro fertilization. Hum Reprod 13 (1998) 1696-1701
5. Strandell A., Lindhard A., Waldenstrom U., and Thorburn J. Hydrosalpinx and IVF outcome: cumulative results after salpingectomy in a randomzed controlled trial. Hum Reprod 16 (2001) 2403-2410
6. Dechaud H., Daures J.P., Amal F., Humeau C., and Hedon B. Does previous salpingectomy improve implantation and pregnancy rates in patients with severe tubal factor infertility who are undergoing in vitro fertilization? A pilot prospective randomized study. Fertil Steril 69 (1998) 1020-1025
7. Goldstein D.B., Sasaran L.H., Stadtmaner L., and Popa R. Selective salpingostomy-salpingectomy and medical treatment prior to IVF in patients with hydrosalpinx. Fertil Steril 70 Suppl 1 (1998) S320
8. Strandell A., Lindhard A., Waldenstrom U., Thorburn J., Janson P.O., and Hamberger L. Hydrosalpinx and IVF outcome: a prospective randomized multicenter trial in Scandinavia on salpingectomy prior to IVF. Hum Reprod 14 (1999) 2762-2769
9. Kontoravdis A., Makrakis E., Pantos K., Botsis D., Deligeoroglou E., and Creatsas G. Proximal tubal occlusion and salpingectomy result in similar improvement in in vitro fertilization outcome in patients with hydrosalpinx. Fertil Steril 86 (2006) 1642-1649
10. Johnson N.P., Mak W., and Sowter M.C. Surgical treatment for tubal disease in women due to undergo in vitro fertilisation. Cochrane Database Syst Rev 3 (2004) CD002125
11. Wever D.J., Veldhuizen A.G., Sanser M.M., Schakenraad J.M., and van Horn J.R. Cytotoxic, allergic, and genotoxic activity of a nickel-titanium alloy. Biomaterials 18 (1997) 1115-1120
12. Sallam H.N., Garcia-Velasco J.A., Diaz S., and Arici A. Long-term pituitary down-regulation before in vitro fertilisation (IVF) for women with endometriosis. Cochrane Database Syst Rev (2006) 4
13. Kerin J.F., Cooper J.M., Price T., Van Herendael B.J., Cayuela-Font E., Cher D., et al. Hysteroscopic sterilization using a micro-insert device: results of a multicentre phase II study. Hum Reprod 18 (2003) 1233-30
14. Practice committee of the American Society for Reproductive Medicine. Salpingectomy for hydrosalpinx prior to IVF. Fertil Steril 82 (2004) 117-119
15. Rosenfield R.B., Stones R.E., Coates A., Matteri R.K., and Hesla J.S. Proximal occlusion of hydrosalpinx by hysteroscopic placement of microinsert before in vitro fertilization-embryo transfer. Fertil Steril 83 (2005) 1547-1550
16. Kerin J.F., and Cattanach S. Successful pregnancy outcome with the use of in vitro fertilization after Essure® hysteroscopic sterilization. Fertil Steril 87 (2007) 1212.e1-1212.e4
17. Galen D.I. Utilization of the Essure® microinsert for the treatment of hydrosalpinx prior to IVF. Fertil Steril 88 Suppl 1 (2007) 16
18. Hitkari J.A., Singh S.S., Shapiro H.M., and Leyland N. Essure® treatment of hydrosalpinges. Fertil Steril 88 (2007) 1663-1666
19. Kerin J.F. Tissue encapsulation of the Essure device from the uterine cavity after hysteroscopic sterilization. J Minim Invasive Gynecol 14 (2007) 202-204